Log In
Print
BCIQ
Print
Print this Print this
 

tizanidine (Zanaflex)

  Manage Alerts
Collapse Summary General Information
Company Acorda Therapeutics Inc.
DescriptionAdrenergic receptor alpha 2 (ADRA2) agonist
Molecular Target Adrenergic receptor alpha 2 (ADRA2)
Mechanism of ActionAdrenergic receptor alpha 2 (ADRA2) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationSpasticity
Indication DetailsTreat muscle spasticity; Treat spasticity of spinal cord origin
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today